Legend Biotech (NASDAQ:LEGN – Get Rating) had its price objective boosted by Barclays from $65.00 to $90.00 in a research note released on Friday, The Fly reports. Several other brokerages have also issued reports on LEGN. BTIG Research raised their target price on Legend Biotech from $75.00 to $85.00 and gave the company a buy […]
Legend Biotech (NASDAQ:LEGN – Get Rating) had its price objective boosted by research analysts at Royal Bank of Canada from $74.00 to $83.00 in a research note issued to investors on Friday, The Fly reports. Royal Bank of Canada’s price target suggests a potential upside of 18.42% from the stock’s current price. Other equities analysts […]
TimesSquare Capital Management LLC grew its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Get Rating) by 0.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 946,500 shares of the company’s stock after buying an additional 5,200 shares during the quarter. […]
Legend Biotech (NASDAQ:LEGN – Get Rating) had its target price raised by stock analysts at BMO Capital Markets from $79.00 to $90.00 in a research note issued to investors on Tuesday, The Fly reports. BMO Capital Markets’ price objective would indicate a potential upside of 32.24% from the company’s current price. Other equities research analysts […]
Legend Biotech (NASDAQ:LEGN – Get Rating) had its price objective upped by HC Wainwright from $66.00 to $77.00 in a research report released on Thursday morning, The Fly reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Legend Biotech’s Q1 2023 earnings at ($0.43) EPS, Q2 2023 […]